The importance of CEA as a biomarker is also emphasized by the fact that calcitonin and CGRP can be expressed in various other neuroendocrine neoplasms, including those originating in lung, pancreas, head and neck, as well as rare examples of paragangliomas and parathyroid carcinomas (54). This evidence concerns the gene CALCA and neuroendocrine neoplasm.